title: Tumor-derived activated cells: culture conditions and characterization.
authors.affiliation: Biotherapeutics, Inc., Franklin, Tennessee.
authors.forename: J R
authors.initials: JR
authors.lastname: Maleckar
authors.forename: C S
authors.initials: CS
authors.lastname: Friddell
authors.forename: W M
authors.initials: WM
authors.lastname: Lewko
authors.forename: J R
authors.initials: JR
authors.lastname: Yannelli
authors.forename: W H
authors.initials: WH
authors.lastname: West
authors.forename: R K
authors.initials: RK
authors.lastname: Oldham
mesh_terms: D002478:Cells, Cultured; D006801:Humans; D016219:Immunotherapy, Adoptive; D007376:Interleukin-2 / Q000494:pharmacology; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D008213:Lymphocyte Activation; D016246:Lymphocytes, Tumor-Infiltrating / Q000276:immunology*; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D011994:Recombinant Proteins / Q000494:pharmacology
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins